Peter Attia· MD
so I think the only way we can use these inflammatory markers is hey if apob is high or LP little a two major risk factors and these inflammatory markers coexist with them I worry about you perhaps a little more
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so I think the only way we can use these inflammatory markers is hey if apob is high or LP little a two major risk factors and these inflammatory markers coexist with them I worry about you perhaps a little more
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but that doesn't mean if apob is high or LP little a is high and your inflammatory markers are perfect that we dismiss you as aha you're the one who's not going to get atherosclerosis cuz that's not a game you want to play